Real-Time PCR, Digital PCR, And End-Point PCR Market Size And Growth Forecast, 2026-2033 Market To Reach USD 21.31 Billion As Precision Medicine Drives 9.2% CAGR


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Prioritize digital PCR, multiplex assays, point-of-care testing and automation to capture demand for precision medicine, early diagnostics and high-throughput workflows.

Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "Real-Time PCR, Digital PCR, and End-Point PCR Market Size, Share & Trends Analysis Report by Technology, Product, Application, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global real-time PCR, digital PCR, and end-point PCR market was valued at USD 10.58 billion in 2025 and is projected to reach USD 21.31 billion by 2033, expanding at a CAGR of 9.2% from 2026 to 2033. Growth is supported by the increasing prevalence of infectious diseases, cancer, chronic conditions, and genetic disorders, alongside rising demand for early diagnosis, precision medicine, and accurate disease monitoring.

Greater use of PCR-based diagnostics for HIV, HPV, Alzheimer's disease, Streptococcal infections, Turner syndrome, Parkinson's disease, and other conditions is expanding the target patient population. According to a WHO report published in July 2025, approximately 1.3 million people globally acquired HIV. European surveillance data also recorded more than 105,922 HIV diagnoses in 2024, with several countries reporting upward trends. These developments continue to increase demand for sensitive molecular diagnostic technologies across clinical laboratories and healthcare systems.

Prenatal genetic testing represents another important growth opportunity. A CDC report from December 2025 indicated that congenital heart defects affect approximately 1% of births annually in the U.S. PCR technologies support the early detection of genetic variations, helping clinicians make timely diagnostic and treatment decisions.

Digital PCR and Precision Medicine

The growing adoption of digital PCR is strengthening the market's role in precision medicine, oncology, infectious disease monitoring, and genetic testing. Digital PCR provides absolute quantification, high sensitivity, strong reproducibility, and accurate detection of rare genetic mutations. These capabilities are supporting wider use in clinical diagnostics and advanced research applications.

Product innovation is accelerating adoption. In July 2025, Bio-Rad expanded its Droplet Digital PCR portfolio by launching the QX Continuum and QX700 systems, which support more than 400,000 assays. The expansion enhances laboratory access to scalable digital PCR solutions for precision diagnostics and high-value healthcare applications.

Multiplex PCR, Automation, and Point-of-care Testing

Advances in multiplex PCR and assay development are improving diagnostic throughput, accuracy, and laboratory productivity. Multiplex systems can detect multiple pathogens within a single test while reducing turnaround time, operational costs, and sample requirements. In November 2025, FlashDx introduced a fully automated multiplex real-time PCR system based on semi-solid phase real-time PCR technology, supporting an integrated sample-to-result workflow and rapid multi-pathogen detection.

A study published in January 2026 also presented a multiplex RT-qPCR assay capable of detecting 18 respiratory viruses simultaneously. The assay demonstrated sensitivity of up to 99.81% and specificity of 100%, highlighting the potential of multiplex testing to improve respiratory disease diagnosis and laboratory efficiency.

Demand for point-of-care and decentralized testing is also increasing. Portable and miniaturized PCR platforms support faster testing in clinics, airports, and remote locations while strengthening pandemic preparedness and on-site diagnostic capacity. At the same time, laboratories are investing in automated, high-throughput systems that can process large sample volumes with minimal manual intervention, helping reduce errors and improve operational performance.

Report Segmentation

The report analyzes market revenue, growth opportunities, competitive dynamics, and emerging trends across technology, product, application, and regional segments for 2021-2033.

  • Technology: Quantitative PCR, digital PCR, and end-point PCR, including consumables & reagents, instruments, and software & services.
  • Product: Consumables & reagents, instruments, and software & services.
  • Application: Clinical testing, pathogen testing, oncology testing, blood screening, liquid biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), research, stem cell research, DNA cloning & sequencing, recombinant DNA technology, rare mutation detection, gene expression, single cell analysis, microbiome analysis, copy number variation analysis, library quantification (NGS), species identification, GMO detection, and forensic applications.
  • Regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with analysis of major national markets including the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Saudi Arabia, UAE, and South Africa.

Business Value of the Report

  • Detailed market estimates and forecasts across major technologies, products, applications, and regions.
  • Analysis of market drivers, future trends, growth opportunities, and product innovation.
  • Competitive landscape assessment, including market presence and strategic positioning.
  • Segment and regional revenue forecasts to support market evaluation and investment planning.
  • Actionable insights for identifying revenue opportunities and guiding strategic business decisions.

Key Attributes:

Report Attribute Details
No. of Pages 120
Forecast Period 2025 - 2033
Estimated Market Value (USD) in 2025 $10.58 Billion
Forecasted Market Value (USD) by 2033 $21.31 Billion
Compound Annual Growth Rate 9.2%
Regions Covered Global


Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Product
1.2.3. Application
1.2.4. Estimates and forecasts timeline
1.3. Objectives
1.3.1. Objective-1
1.3.2. Objective-2
1.3.3. Objective-3
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased database
1.5.2. internal database
1.5.3. Secondary sources
1.5.4. Primary research
1.6. Information or Data Analysis
1.6.1. Data analysis models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity flow analysis
1.9. List of Secondary Sources
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Technology Snapshot
2.3. Product Snapshot
2.4. Application Snapshot
2.5. Competitive Insights
Chapter 3. Real Time PCR, Digital PCR and End-Point PCR Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook (Drug Testing Market)
3.1.2. Related/ancillary market outlook (Drug Screening Market)
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Real Time PCR, Digital PCR and End-Point PCR Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
3.4. Regulatory Framework
3.5. Reimbursement Scenario
Chapter 4. Real Time PCR, Digital PCR and End-Point PCR Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Real Time PCR, Digital PCR and End-Point PCR Market: Technology Movement Analysis
4.3. Real Time PCR, Digital PCR and End-Point PCR Market by Technology Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Quantitative
4.5.1. Quantitative Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Consumables & reagents
4.5.3. Instruments
4.5.4. Software & Services
4.5.5. Software & Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Digital
4.6.1. Digital market estimates and forecast, 2021-2033 (USD Million)
4.6.2. Consumables & Reagents
4.6.3. Instruments
4.6.4. Software & Services
4.7. End-point PCR
4.7.1. End-point PCR market estimates and forecast, 2021-2033 (USD Million)
4.7.2. Consumables & Reagents
4.7.3. Instruments
4.7.4. Software & Services
Chapter 5. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2021-2033 (Revenue, USD Million)
5.1. Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
5.2. Consumables & Reagents
5.2.1. Consumables & Reagents market estimates and forecast, 2021-2033 (USD Million)
5.3. Instruments
5.3.1. Instruments market estimates and forecast, 2021-2033 (USD Million)
5.4. Software & Services
5.4.1. Software & Services market estimates and forecast, 2021-2033 (USD Million)
Chapter 6. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2021-2033 (Revenue, USD Million)
6.1. Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis
6.2. Clinical
6.2.1. Clinical market estimates and forecast, 2021-2033 (USD Million)
6.2.2. Pathogen Testing
6.2.3. Oncology Testing
6.2.4. Blood Screening
6.2.5. Liquid Biopsy Testing
6.2.6. dPCR-based Non-Invasive Prenatal Testing (NIPT)
6.2.7. Others
6.3. Research
6.3.1. Research market estimates and forecast, 2021-2033 (USD Million)
6.3.2. Stem Cell Research
6.3.3. DNA Cloning & Sequencing
6.3.4. Recombinant DNA Technology
6.3.5. Rare Mutation Detection
6.3.6. Gene Expression
6.3.7. Single-Cell Analysis
6.3.8. Microbiome Analysis
6.3.9. Copy Number Variation Analysis
6.3.10. Library Quantification (NGS)
6.3.11. Characterization of Low-fold Changes in mRNA and miRNA Expression
6.3.12. Species Identification
6.3.13. GMO Detection
6.4. Forensics and Others
Chapter 7. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2021-2033 (Revenue, USD Million)
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033
7.5. North America
7.5.1. U.S.
7.5.2. Canada
7.5.3. Mexico
7.6. Europe
7.6.1. UK
7.6.2. Germany
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Norway
7.6.7. Sweden
7.6.8. Denmark
7.7. Asia-Pacific
7.7.1. Japan
7.7.2. China
7.7.3. India
7.7.4. Australia
7.7.5. South Korea
7.7.6. Thailand
7.8. Latin America
7.8.1. Brazil
7.8.2. Argentina
7.9. MEA
7.9.1. South Africa
7.9.2. Saudi Arabia
7.9.3. UAE
7.9.4. Kuwait
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.4. List of key distributors and channel partners
8.5. Key customers
8.6. Key company market share analysis, 2025
8.7. Company Profiles
8.7.1. Abbott
8.7.2. QIAGEN
8.7.3. Bio-Rad Laboratories, Inc.
8.7.4. Agilent Technologies, Inc.
8.7.5. Thermo Fisher Scientific, Inc.
8.7.6. GE Healthcare
8.7.7. BioMerieux SA
8.7.8. F. Hoffmann-La Roche Ltd
8.7.9. Fluidigm Corporation
List of Tables [94]
List of Figures [83]
Companies Featured

  • Abbott
  • Qiagen
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • bioMerieux
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN20112026004107003653ID1111996985


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search